Apolipoprotein A5 Antibody (4H8H8E2) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NB110-57307H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
HRP
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # 4H8H8E2
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Ni-NTA purified full-length recombinant human Apolipoprotein A5 expressed in E. Coli strain BL21 (DE3). [UniProt# Q6Q788]
Localization
Secreted
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for Apolipoprotein A5 Antibody (4H8H8E2) [HRP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Apolipoprotein A5
Alternate Names
APOAV, apo-AV, APOA-V, Apolipoprotein A5, apolipoprotein A-V, FLJ97995, MGC126836, RAP3MGC126838, Regeneration-associated protein 3
Gene Symbol
APOA5
Additional Apolipoprotein A5 Products
Product Documents for Apolipoprotein A5 Antibody (4H8H8E2) [HRP]
Product Specific Notices for Apolipoprotein A5 Antibody (4H8H8E2) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...